Home › Funds › PFM Health Sciences, LP › HUM
PFM Health Sciences, LP position in HUM
HUMANA INC · Health Care
PFM Health Sciences, LP reported holding 51,078 shares of HUM (HUMANA INC) in its Q3 2026 13F filing — a position valued at US$19.5M, representing 1.99% of its reported portfolio and ranking #15 among its reported holdings. PFM Health Sciences, LP has disclosed HUM holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's HUM position evolved
PFM Health Sciences, LP first disclosed a stake in HUM in Q3 2023 at 166,066 shares (US$80.8M). Across 11 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 51,078 shares valued at US$19.5M — a reduction of -43,297 shares quarter over quarter.. Notable position changes include a 73% increase in Q2 2025 (shares rose 7% over the following quarter), a 97% trim in Q3 2025 (shares fell 1% over the following quarter), a 46% trim in Q3 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 166.07K | $80.79M | New |
| Q4 2023 | 125.34K | $57.38M | Reduce |
| Q1 2024 | 125.34K | $43.46M | Hold |
| Q2 2024 | 125.34K | $46.83M | Hold |
| Q3 2024 | 101.95K | $32.29M | Reduce |
| Q4 2024 | 83.04K | $21.07M | Reduce |
| Q1 2025 | 63.24K | $16.73M | Reduce |
| Q2 2025 | 109.51K | $26.77M | Add |
| Q3 2025 | 3.65K | $949.10K | Reduce |
| Q2 2026 | 94.38K | $37.49M | New |
| Q3 2026 | 51.08K | $19.49M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HUM and 13F data
HUM (HUMANA INC) is a Health Care company. 31 other funds we track also report a position in HUM — the largest reported positions include Dodge & Cox (US$4.35B), DODGE & COX (US$3.90B), EAGLE CAPITAL MANAGEMENT LLC (US$1.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HUM
- Dodge & Cox 10.94M sh · $4.35B · Q2 2026
- DODGE & COX 10.23M sh · $3.90B · Q3 2026
- EAGLE CAPITAL MANAGEMENT LLC 3.85M sh · $1.53B · Q2 2026
- Sessa Capital IM, L.P. 3.73M sh · $1.48B · Q2 2026
- Pzena Investment Management 3.65M sh · $1.39B · Q3 2026
- NAYA CAPITAL MANAGEMENT UK LTD 1.83M sh · $728.41M · Q2 2026
- Assenagon Asset Management S.A. 1.26M sh · $479.05M · Q3 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held HUM?
PFM Health Sciences, LP has disclosed HUM holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is PFM Health Sciences, LP's current position in HUM?
As of Q3 2026, PFM Health Sciences, LP holds 51.08K shares of HUM (HUMANA INC), valued at $19.49M, representing 1.99% of its reported portfolio and ranking #15.
Has PFM Health Sciences, LP been buying or selling HUM?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP reduced its position in HUM.
Which other funds hold HUM?
Other major institutional holders of HUM include Dodge & Cox, DODGE & COX, EAGLE CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.